Option Greeks measure how LandBridge Corporation (LB) option prices respond to changes in the stock price (delta and gamma), the passage of time (theta), implied volatility (vega), and interest rates (rho). These charts plot each Greek by strike, so you can see where an expiration's price risk, time decay, and volatility exposure are concentrated. LB implied volatility is near the bottom of its one-year range, which keeps delta and gamma in a narrower range of strikes than usual.
Upgrade to view higher order greeks (Vanna, Charm, and Vomma) and multiple expiration dates.
LB Option Greeks FAQ
What are option Greeks?
Option Greeks measure how an option's price responds to changes in the stock price (delta and gamma), time (theta), implied volatility (vega), and interest rates (rho).
How do I read the LB Greeks charts?
Gamma, theta, and vega are largest for strikes near the LandBridge stock price and shrink for strikes far above or below it. Theta grows as expiration gets closer, while vega is larger for expirations further out. Call delta runs from 0 to 1 and put delta from -1 to 0, near 0.50 and -0.50 at the money, and roughly estimates the chance that an option finishes in the money.
How does implied volatility affect LB's Greeks?
LandBridge IV rank is 11, so implied volatility is near the bottom of its one-year range. Higher implied volatility raises option premiums and daily time decay (theta), and spreads delta and gamma across a wider range of strikes. Over the past year, 30-day implied volatility ranged from 45.1% to 194.5%. See the LB implied volatility history for a longer view.
How much gamma and delta do LB options carry in total?
Across all open LandBridge options on Nov 4, 2026, net gamma exposure was $76.26K and net delta exposure was $2.29M per 1% move in the stock. The LB gamma exposure chart shows where that gamma sits by strike.
What is LandBridge Corporation?
LandBridge Corp specializes in actively managing land and resources to support and promote energy production and other commercial and industrial development.